Optiscan Imaging (ASX:OIL) Tax Provision : A$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Optiscan Imaging Tax Provision?

Optiscan Imaging's tax provision for the six months ended in Dec. 2023 was A$0.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Optiscan Imaging Tax Provision Historical Data

The historical data trend for Optiscan Imaging's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optiscan Imaging Tax Provision Chart

Optiscan Imaging Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Tax Provision

Get a 7-Day Free Trial

Optiscan Imaging Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Tax Provision	Get a 7-Day Free Trial															-	-	-	-	-

Optiscan Imaging Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Optiscan Imaging (ASX:OIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Optiscan Imaging Ltd (ASX:OIL) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Miles Street, Mulgrave, Melbourne, VIC, AUS, 3170

Website

https://www.optiscan.com

Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation.